Adrenal myelolipoma is a rare, benign tumor of the adrenal gland that is composed of mature fat and bone marrow cells. It is most commonly found in adults and is usually asymptomatic. However, in some cases, it can cause complications due to its size and location. In this article, we will explore the impact of adrenal myelolipoma on the human body and discuss the diagnosis, treatment, and management of this condition.
Adrenal myelolipoma (AML) is a rare benign tumor of the adrenal gland composed of mature fat and bone marrow cells. It is most commonly found in adults, usually asymptomatic, and is usually discovered incidentally during imaging. The tumor is usually small, less than 5cm in diameter, and is located in the adrenal cortex. It is important to note that AML is not cancerous and does not spread outside of the adrenal gland.
The exact cause of adrenal myelolipoma is not known, but there are some risk factors that may increase the likelihood of developing this condition. These include:
Adrenal myelolipoma is usually asymptomatic and is usually discovered incidentally during imaging. However, in some cases, it can cause complications due to its size and location. The most common symptoms of AML include:
The diagnosis of adrenal myelolipoma is usually made through imaging studies, such as CT or MRI scans. These scans can help to identify the size and location of the tumor. In some cases, a biopsy may be performed to confirm the diagnosis.
Adrenal myelolipoma is usually asymptomatic and does not require treatment. However, if the tumor is large or is causing complications, surgery may be recommended to remove it. In some cases, medications may be prescribed to manage symptoms or to reduce the size of the tumor.
Adrenal myelolipoma is a rare, benign tumor of the adrenal gland that is composed of mature fat and bone marrow cells. It is most commonly found in adults and is usually asymptomatic. However, in some cases, it can cause complications due to its size and location. Diagnosis is usually made through imaging studies, and treatment may include surgery or medication to manage symptoms. It is important to recognize the potential impact of adrenal myelolipoma on the human body and to be aware of the diagnosis, treatment, and management of this condition.
1.
De-Intensified Therapy Misses Mark in HPV-Positive Oropharyngeal Cancer
2.
Patients With Melanoma Brain Mets May Fare Better With RT Before Immunotherapy
3.
Immune cell homing hydrogel-based platform captures dendritic cells to process mRNA from cancer vaccines
4.
Study finds 81% of cancer cures touted by TikTok videos are fake
5.
Invest in generics as a lesson from the shortages of chemotherapy.
1.
Mastering Oncology RCM: Reducing Errors, Denials & Improving Billing Efficiency
2.
Cardio-Oncology in Survivors: Safeguarding Hearts Through Multidisciplinary Care
3.
Blastic Plasmacytoid Dendritic Cell Neoplasm and the Dawn of AI-powered Diagnostics
4.
Thyroidectomy & Survival: Highlights from ASCO 2025 and Current U.S. Findings
5.
Targeted Approaches to Breast Cancer Liver Metastases: Surgery, Ablation, and Survival Insights
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
2.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
3.
Updates on Standard V/S High Risk Myeloma Treatment
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
5.
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation